1
|
Belliveau C, Barkati M, Delouya G, Taussky D, Beauchemin MC, Lambert C, Beaulieu L, Beliveau-Nadeau D, Nicolas B, Carrier JF, Vigneault E, Ménard C. Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial. Radiat Oncol 2022; 17:203. [PMID: 36494834 PMCID: PMC9733116 DOI: 10.1186/s13014-022-02173-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2022] [Accepted: 11/30/2022] [Indexed: 12/13/2022] Open
Abstract
BACKGROUND For patients with a higher burden of localized prostate cancer, radiation dose escalation with brachytherapy boosts have improved cancer control outcomes at the cost of urinary toxicity. We hypothesize that a focal approach to brachytherapy boosts targeting only grossly visualized tumor volumes (GTV) combined with stereotactic radiotherapy will improve quality of life (QoL) outcomes without compromising cancer control. METHODS 150 patients with intermediate or high-risk prostate cancer will be enrolled and randomized 1:1 in a cohort multiple randomized clinical trial phase 2 design. Patients are eligible if planned for standard-of-care (SOC) high dose rate (HDR) brachytherapy boost to radiotherapy (RT) with GTVs encompassing < 50% of the prostate gland. Those randomly selected will be offered the experimental treatment, consisting of focal HDR brachytherapy boost (fBT) of 13-15 Gy in 1 fraction followed by stereotactic radiotherapy (sRT) 36.25-40 Gy in 5 fractions to the prostate (+/- 25 Gy to the elective pelvis) delivered every other day. The primary endpoint is to determine if fBTsRT is superior to SOC by having fewer patients experience a minimally important decline (MID) in urinary function as measured by EPIC-26 at 1 and 2 years. Secondary endpoints include rates of toxicity measured by Common Terminology Criteria for Adverse Events (CTCAE), and failure-free survival outcomes. DISCUSSION This study will determine whether a novel approach for the treatment of localized prostate cancer, fBTsRT, improves QoL and merits further evaluation. Trial registration This trial was prospectively registered in ClinicalTrials.gov as NCT04100174 as a companion to registry NCT03378856 on September 24, 2019.
Collapse
Affiliation(s)
- C. Belliveau
- grid.410559.c0000 0001 0743 2111Radiation Oncology, CHUM - Centre Hospitalier de l’Université de Montréal, 900 Saint Denis St, Montreal, QC H2X 0A9 Canada
| | - M. Barkati
- grid.410559.c0000 0001 0743 2111Radiation Oncology, CHUM - Centre Hospitalier de l’Université de Montréal, 900 Saint Denis St, Montreal, QC H2X 0A9 Canada
| | - G. Delouya
- grid.410559.c0000 0001 0743 2111Radiation Oncology, CHUM - Centre Hospitalier de l’Université de Montréal, 900 Saint Denis St, Montreal, QC H2X 0A9 Canada
| | - D. Taussky
- grid.410559.c0000 0001 0743 2111Radiation Oncology, CHUM - Centre Hospitalier de l’Université de Montréal, 900 Saint Denis St, Montreal, QC H2X 0A9 Canada
| | - M. C. Beauchemin
- grid.410559.c0000 0001 0743 2111Radiation Oncology, CHUM - Centre Hospitalier de l’Université de Montréal, 900 Saint Denis St, Montreal, QC H2X 0A9 Canada
| | - C. Lambert
- grid.410559.c0000 0001 0743 2111Radiation Oncology, CHUM - Centre Hospitalier de l’Université de Montréal, 900 Saint Denis St, Montreal, QC H2X 0A9 Canada
| | - L. Beaulieu
- grid.23856.3a0000 0004 1936 8390Radiation Oncology, Centre universitaire de Québec, Université Laval, 2705 Laurier Boulevard, Quebec City, QC G1V 4G2 Canada
| | - D. Beliveau-Nadeau
- grid.410559.c0000 0001 0743 2111Radiation Oncology, CHUM - Centre Hospitalier de l’Université de Montréal, 900 Saint Denis St, Montreal, QC H2X 0A9 Canada
| | - B. Nicolas
- grid.410559.c0000 0001 0743 2111Radiation Oncology, CHUM - Centre Hospitalier de l’Université de Montréal, 900 Saint Denis St, Montreal, QC H2X 0A9 Canada
| | - J. F. Carrier
- grid.410559.c0000 0001 0743 2111Radiation Oncology, CHUM - Centre Hospitalier de l’Université de Montréal, 900 Saint Denis St, Montreal, QC H2X 0A9 Canada
| | - E. Vigneault
- grid.23856.3a0000 0004 1936 8390Radiation Oncology, Centre universitaire de Québec, Université Laval, 2705 Laurier Boulevard, Quebec City, QC G1V 4G2 Canada
| | - C. Ménard
- grid.410559.c0000 0001 0743 2111Radiation Oncology, CHUM - Centre Hospitalier de l’Université de Montréal, 900 Saint Denis St, Montreal, QC H2X 0A9 Canada
| |
Collapse
|
2
|
Dewaele A, Henry L, Fréville R, Denoual C, Guignot N, King A, Nicolas B, Boulard E, Legodec Y, Garbarino G. Microstructures induced by phase transformations under extreme conditions. Acta Cryst Sect A 2022. [DOI: 10.1107/s2053273322096619] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/19/2023]
|
3
|
Samson M, Nicolas B, Guilhem A, Greigert H, Ciudad M, Cladiere C, Straub C, Blot M, Piroth L, Rogier T, Devilliers H, Manckoundia P, Ghesquiere T, Francois S, Lakomy D, Audia S, Bonnotte B. L’augmentation du pourcentage de lymphocytes Th17 est associée à un risque d’évolution vers une forme grave d’infection à SARS-CoV-2. Rev Med Interne 2022. [PMCID: PMC9212761 DOI: 10.1016/j.revmed.2022.03.291] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Introduction Depuis décembre 2019, plus de 20 millions de français ont été infectés par le SARS-CoV-2 et plus de 130 000 en sont décédés. La physiopathologie de cette infection n’est pas totalement élucidée. Il a été démontré qu’elle provoquait une importante sécrétion de cytokines pro-inflammatoires, en particulier d’interleukine-6 (IL-6) [1]. Lorsque les patients infectés sont hospitalisés, ils reçoivent généralement de la dexaméthasone et parfois un traitement anti-infectieux. Si la maladie s’aggrave, le tocilizumab peut être ajouté [2]. Actuellement, seule l’évolution clinique incite à débuter le tocilizumab, mais parfois trop tardivement. Il manque aux cliniciens un marqueur précoce leur permettant de prédire le risque d’aggravation de la maladie. Cette étude, menée chez des patients hospitalisés pour infection à SARS-CoV-2 pendant la 2e vague, avait pour objectif de rechercher un marqueur d’aggravation de la maladie en comparant la réponse lymphocytaire entre les patients évoluant vers une forme grave et les autres. Patients et méthodes Les patients hospitalisés pour infection à SARS-CoV-2 prouvée par RT-PCR datant de moins d’une semaine ont été inclus prospectivement dans cette étude monocentrique. Une infection grave était définie par un transfert en soins intensifs, en réanimation ou le décès. Des prélèvements sanguins ont été obtenus à l’admission à l’hôpital et avant de débuter la corticothérapie afin d’étudier les sous-populations lymphocytaires par cytométrie en flux et doser l’IL-6 plasmatique par immunofluorimétrie. Les données sont exprimées en nombre (%) ou médiane (espace inter-quartile). Résultats De septembre à décembre 2020, 37 patients (18 hommes, 19 femmes) hospitalisés pour infection à SARS-Cov2 ont été inclus : âge = 81,7 (70,3–87,5) ans, IMC = 25,7 (23,7–29) kg/m2, hypertension artérielle (54 %), diabète (24 %), dyslipidémie (35 %), tabagisme (24 %), cardiopathie ischémique (8 %), maladie cérébrovasculaire (11 %). La durée de suivi était de 10 (8–15) jours. Parmi les 37 patients inclus, 11 (30 %) ont présenté une infection à SARS-CoV-2 grave dont 4 transferts en réanimation et 8 décès. À l’admission, les patients ayant une infection évoluant vers une forme grave étaient plus âgés (p = 0,021), avaient une créatininémie plus élevée (p = 0,003) et une diminution du pourcentage de lymphocytes B (p = 0,04), de lymphocytes T (p = 0,009) et de lymphocytes T CD4+ (p = 0,004) circulants parmi les lymphocytes totaux comparativement aux patients dont l’évolution était favorable. Parmi les sous-populations lymphocytaires T étudiées (mémoires, naïfs, Th1, Th2, Th17, Treg, Tc1, Tc17, T CD8 cytotoxiques), il n’y avait pas de différence significative entre les deux groupes en dehors du pourcentage de lymphocytes Th17 à l’admission qui était deux fois plus élevé chez les patients dont l’infection évoluait vers une forme grave (0,44 vs 0,23 % des LT CD4 totaux ; p = 0,028). Chez les patients ayant une infection évoluant vers une forme grave, l’IL-6 plasmatique à l’admission était plus élevée (39 vs 13,1 pg/mL ; p = 0,018) et la CRP à l’admission avait tendance à être plus élevée sans atteindre le seuil de significativité (58 vs 18,5 mg/L ; p = 0,17). En analyse multivariée (régression logistique binaire comprenant les variables : âge, créatininémie, CRP, hémoglobine, lymphocytes T CD4, Th17, Treg activés (CD4 + CD45RA-FoxP3high), lymphocytes B, IL-6 sérique), la seule variable associée au risque d’évolution vers une forme grave de l’infection était le pourcentage de lymphocytes Th17 circulants (p = 0,034). L’aire sous la courbe de la courbe ROC évaluant la sensibilité et la spécificité du pourcentage de lymphocytes Th17 pour prédire une forme grave d’infection à SARS-CoV-2 chez un patient hospitalisé était de 0,75 (intervalle de confiance à 95 % : 0,56–0,95). Enfin, le fait d’avoir un pourcentage de lymphocytes Th17 > 0,435 % des lymphocytes T CD4 totaux au moment de l’admission en hospitalisation était associé à une moins bonne survie (p = 0,024). Conclusion Cette étude suggère qu’une élévation du pourcentage de lymphocytes Th17 chez des patients hospitalisés pour infection à SARS-CoV-2 augmente significativement le risque d’évolution vers une forme grave de la maladie. Ce résultat est cohérent avec le fait qu’il a été démontré que le tocilizumab, qui est efficace dans le traitement des formes graves de COVID-19 [2], inhibe la réponse lymphocytaire Th17 [3]. Ces données méritent d’être confirmées chez un plus grand nombre de patients afin de confirmer ce résultat car cette mesure pourrait permettre de mieux cibler la population de patients à qui proposer précocement un traitement par tocilizumab pour diminuer le risque d’évolution vers une forme grave d’infection à SARS-CoV-2.
Collapse
|
4
|
Louis T, Wargny M, De Saint Riquier M, Nicolas B, Cazalets C, Jego P, Droitcourt C, Coiffier G, Lescoat A. Valeur prédictive des paramètres échographiques de la main sur la survenue des atteintes viscérales sclérodermiques au cours d’une étude longitudinale monocentrique. Rev Med Interne 2022. [DOI: 10.1016/j.revmed.2022.03.262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
5
|
Barlesi F, Dixmier A, Debieuvre D, Raspaud C, Auliac J, Nicolas B, Bombaron P, Moro-Sibilot D, Audigier-Valette C, Asselain B, Dumanoir J, Cotté FE, Allan V, Calvet C, Reynaud D, Pérol M. 1348P Long-term survival and health-related quality of life with nivolumab for previously-treated advanced non-small cell lung cancer (NSCLC): A wide prospective French real-world study (EVIDENS). Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1949] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
6
|
Coussement A, Nevado S, Simon E, Berthier S, Nicolas B, Samson M, Bonnotte B, Audia S. Grossesse compliquée d’une hémophagocytose lymphohistiocytaire secondaire à une infection à Parvovirus B19. Rev Med Interne 2021. [DOI: 10.1016/j.revmed.2021.03.124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
7
|
Guilhem A, Cladiere C, Ciudad M, Audia S, Berthier S, Nicolas B, Ghesquiere T, Samson M, Leguy-Seguin V, Bonnotte B. Modification de la réponse immunitaire au cours de la maladie de Rendu-Osler. Rev Med Interne 2020. [DOI: 10.1016/j.revmed.2020.10.106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
8
|
Godot A, Guilhem A, Leguy-Seguin V, Berthier S, Nicolas B, Maillet T, Ghesquiere T, Audia S, Samson M, Bonnotte B. Mutation somatique du gène NLRP3 : une cause rare de syndrome inflammatoire prolongé du sujet âgé ! Rev Med Interne 2020. [DOI: 10.1016/j.revmed.2020.10.307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
9
|
Menard C, Lopera D, Shams R, Barkati M, Delouya G, Béliveau-Nadeau D, Nicolas B, Benhacene-Boudam M, Juneau D, DaSilva J, Carrier J, Kadoury S. MRI/PET Directed and TRUS/EM Guided Prostate Tumor Targeted HDR Brachytherapy: Performance of a Prototype System. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.2202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
10
|
Picot D, Gallien P, Duruflé A, Guillou F, Achille-Fauveau S, Colin A, Fraudet B, Nicolas B. La Libre pesée : pour que les personnes en fauteuil roulant connaissent et surveillent leur poids. NUTR CLIN METAB 2020. [DOI: 10.1016/j.nupar.2020.02.251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
11
|
Bador J, Nicolas B, Chapuis A, Varin V, Dullier-Taillefumier N, de Curraize C, Amoureux L, Putot A, Neuwirth C. 16S rRNA PCR on clinical specimens: Impact on diagnosis and therapeutic management. Med Mal Infect 2019; 50:63-73. [PMID: 31611135 DOI: 10.1016/j.medmal.2019.09.014] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2018] [Revised: 12/16/2018] [Accepted: 09/17/2019] [Indexed: 10/25/2022]
Abstract
OBJECTIVE 16S rRNA PCR (16S PCR) performed on clinical samples contributes to bacterial identification in cases of negative culture due to an antibiotic therapy. Sensitivity of the 16S PCR is low (19-42%). Little data is available on its impact on the management of patients. We aimed to evaluate the contribution of 16S PCR to diagnosis and therapeutic management at the university hospital of Dijon, France. PATIENTS AND METHODS 16S PCR was performed on the clinical specimens of 132 patients. Clinical settings, laboratory results, and data on antibiotic therapy were collected, as well as conclusions drawn from the 16S PCR result by physicians. Each case was analyzed to determine if the 16S PCR was helpful. The relevance of the 16S PCR was also assessed. RESULTS The 16S PCR yield was 27.3%, ranging from 14.3% to 64.3% depending on the type of specimen. 16S PCR had a positive impact on diagnosis in 28.8% of cases. Five negative 16S PCR results were considered helpful as they contributed to ruling out bacterial infection. 16S PCR led to treatment changes in six patients (4.5%): three narrower spectrums, two treatment adaptations, and one discontinuation. The 16S PCR was considered "non-relevant" in 35 cases (26.5%). None of these 35 PCRs contributed to the patient's management. CONCLUSION Physicians should be aware of performances of 16S PCR. Dialogue between physicians and bacteriologists is essential for appropriate selection of indications and correct interpretation of results.
Collapse
Affiliation(s)
- J Bador
- Laboratoire de bactériologie, hôpital universitaire de Dijon, BP 37013, 21070 Dijon cedex, France.
| | - B Nicolas
- Laboratoire de bactériologie, hôpital universitaire de Dijon, BP 37013, 21070 Dijon cedex, France
| | - A Chapuis
- Laboratoire de bactériologie, hôpital universitaire de Dijon, BP 37013, 21070 Dijon cedex, France
| | - V Varin
- Laboratoire de bactériologie, hôpital universitaire de Dijon, BP 37013, 21070 Dijon cedex, France
| | - N Dullier-Taillefumier
- Laboratoire de bactériologie, hôpital universitaire de Dijon, BP 37013, 21070 Dijon cedex, France
| | - C de Curraize
- Laboratoire de bactériologie, hôpital universitaire de Dijon, BP 37013, 21070 Dijon cedex, France
| | - L Amoureux
- Laboratoire de bactériologie, hôpital universitaire de Dijon, BP 37013, 21070 Dijon cedex, France
| | - A Putot
- Laboratoire de bactériologie, hôpital universitaire de Dijon, BP 37013, 21070 Dijon cedex, France
| | - C Neuwirth
- Laboratoire de bactériologie, hôpital universitaire de Dijon, BP 37013, 21070 Dijon cedex, France
| |
Collapse
|
12
|
Maldiney T, Leguy-Seguin V, Prevel O, Rajillah A, Thibault T, Chabannes M, Nicolas B, Guilhem A, Berthier S, Audia S, Samson M, Bonnotte B. Une pseudotumeur rénale. Rev Med Interne 2019; 40:698-699. [DOI: 10.1016/j.revmed.2018.12.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2018] [Accepted: 12/18/2018] [Indexed: 11/28/2022]
|
13
|
Robineau S, Nicolas B, Mathieu L, Duruflé A, Leblong E, Fraudet B, Gélis A, Gallien P. Assessing the impact of a patient education programme on pressure ulcer prevention in patients with spinal cord injuries. J Tissue Viability 2019; 28:167-172. [PMID: 31288977 DOI: 10.1016/j.jtv.2019.06.001] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2019] [Revised: 06/02/2019] [Accepted: 06/05/2019] [Indexed: 10/26/2022]
Abstract
OBJECTIVES There is currently a low level of evidence for the impact of patient education on the management of patients with chronic neurological disease at risk of developing pressure ulcers. The objective of this study was to assess the impact of a patient education programme on pressure ulcer prevention in patients with chronic spinal cord injuries. MATERIALS AND METHODS This study included adult patients with any spinal cord injury, regardless of the cause. Participants attended 2 group workshops focusing on pressure ulcer prevention. Various clinical data were gathered during an initial individual interview and at 3, 6 and 12 months, along with rating scale values from the Hospital Anxiety and Depression Scale, Rosenberg self-esteem scale, Schwarzer self-efficacy scale, a quality of life scale (SF-36) and the revised Skin Management Needs Assessment Checklist (Revised SMnac), which was used as the primary endpoint. RESULTS Twenty patients were included in the study. The mean patient age was 52 years (SD: 9,8). Sixteen patients had traumatic spinal cord injuries, with a median injury duration of 234 months (IQR: 123-407). Seventy-five percent had had a pressure ulcer in the twelve months prior to the study. Patient education was shown to have a significant impact on skin management ability, with a highly significant increase in the overall revised SMnac score at 3 months. These results were stable over time, from 6 to 12 months. Six patients developed a pressure ulcer during the study (30%). CONCLUSION This study supports the hypothesis that a therapeutic educational program conducted at the chronic phase in spinal cord injured individuals has an impact.
Collapse
Affiliation(s)
- S Robineau
- Pôle MPR Saint Hélier, 54 Rue Saint Hélier, CS 74330, 35043, Rennes Cedex, France.
| | - B Nicolas
- Pôle MPR Saint Hélier, 54 Rue Saint Hélier, CS 74330, 35043, Rennes Cedex, France
| | - L Mathieu
- Pôle MPR Saint Hélier, 54 Rue Saint Hélier, CS 74330, 35043, Rennes Cedex, France
| | - A Duruflé
- Pôle MPR Saint Hélier, 54 Rue Saint Hélier, CS 74330, 35043, Rennes Cedex, France
| | - E Leblong
- Pôle MPR Saint Hélier, 54 Rue Saint Hélier, CS 74330, 35043, Rennes Cedex, France
| | - B Fraudet
- Pôle MPR Saint Hélier, 54 Rue Saint Hélier, CS 74330, 35043, Rennes Cedex, France
| | - A Gélis
- Centre Mutualiste Neurologique PROPARA, 263 Rue Du Caducée, 34090, Montpellier, France
| | - P Gallien
- Pôle MPR Saint Hélier, 54 Rue Saint Hélier, CS 74330, 35043, Rennes Cedex, France
| |
Collapse
|
14
|
Guilhem A, Ciudad M, Leguy-Seguin V, Nicolas B, Berthier S, Maillet T, Audia S, Samson M, Bonnotte B. Implication des lymphocytes T angiogéniques au cours de la maladie de Rendu–Osler. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
15
|
Gallien P, Leroux R, Nicolas B, Coignard P, Durufle A, Bouton M, Chapelain F, Colin A. Impact of cognitive disorders on schooling and socio-professional integrations in adults with cerebral palsy. Ann Phys Rehabil Med 2018. [DOI: 10.1016/j.rehab.2018.05.743] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
16
|
Duruflé, Mathieu L, Robineau S, Nicolas B, Leblong E, Fraudet B, Gelis A, Gallien P. Evaluation of the impact of a therapeutic educational program concerning the prevention of risk of pressure ulcers for persons with a spinal cord lesion. Ann Phys Rehabil Med 2018. [DOI: 10.1016/j.rehab.2018.05.894] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
17
|
Duruflé, Aubry J, Bordas M, Gallien P, Le Meur C, Nicolas B. Alternative to supply of health services in physical medicine and rehabilitation: From mobile team to home hospitalization. Ann Phys Rehabil Med 2018. [DOI: 10.1016/j.rehab.2018.05.1181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
18
|
Barrois B, Nicolas B, Colin D, Fromy B, Barateau M, Gelis A, Michel J. French national guidelines for pressure ulcer (PU) prevention and care. Ann Phys Rehabil Med 2018. [DOI: 10.1016/j.rehab.2018.05.898] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
19
|
Gallien P, Colin A, Nicolas B, Durufle A, Brion A, Achille-Fauveau S. Access to dental care for people with disabilities in Britanny. Ann Phys Rehabil Med 2018. [DOI: 10.1016/j.rehab.2018.05.952] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
20
|
Barrois B, Michel P, Nicolas B, Colin D, Gelis A, Allaert F. National pressure ulcer (PU) prevalence in French intensive care units for patient with neurological diseases. Ann Phys Rehabil Med 2018. [DOI: 10.1016/j.rehab.2018.05.891] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
21
|
Nicolas B, Putot A, Chapuis A, Varin V, Dullier-Taillefumier N, de Curraize C, Amoureux L, Neuwirth C, Bador J. PCR 16S sur échantillon clinique : évaluation du service rendu sur le plan diagnostique et thérapeutique. Med Mal Infect 2018. [DOI: 10.1016/j.medmal.2018.04.107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
22
|
Auvens C, Bouldoires B, Jeudy G, Bonniaud B, Dalac S, Berthier S, Leguy-Seguin V, Pasteur J, Audia S, Nicolas B, Guilhem A, Bonnotte B. Conduite à tenir devant un cancer indifférencié mettant en jeu le pronostic vital. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.168] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
23
|
Bach B, Samson M, Guilhem A, Nicolas B, Leguy-Seguin V, Berthier S, Lakomy D, Bonnotte B, Audia S. Incidence et caractéristiques des évènements thromboemboliques veineux au cours de l’anémie hémolytique auto-immune à anticorps chauds. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
24
|
Schmitt M, Samson M, Leguy-Seguin V, Robert R, Berthier S, Nicolas B, Guilhem A, Jacquin A, Lakomy D, Cottin Y, Audia S, Bonnotte B. Une cause rare de syndrome dysautonomique. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
25
|
Jacquier M, Samson M, Audia S, Leguy-Seguin V, Berthier S, Nicolas B, Falvo N, Guilhem A, Krause D, Loffroy R, Steinmetz E, Bonnotte B. Dissection aortique traitée par corticothérapie. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.206] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
26
|
Estève C, Samson M, Guilhem A, Nicolas B, Leguy-Seguin V, Berthier S, Bonnotte B, Audia S. Efficacité et tolérance de la dapsone en traitement de seconde ligne de la thrombopénie immunologique de l’adulte. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
27
|
Maillet T, Samson M, Guilhem A, Nicolas B, Leguy-Seguin V, Berthier S, Bonnotte B, Audia S. Une cause rare de monocytopénie…. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.233] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
28
|
Maillet T, Leguy-Seguin V, Samson M, Guilhem A, Nicolas B, Berthier S, Bonnotte B, Audia S. Pseudotumeur rénale : une forme trompeuse de maladie associée aux IgG4. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.264] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
29
|
Spanjaard M, Guilhem A, Collet E, Nicolas B, Leguy-Seguin V, Berthier S, Samson M, Bonnotte B, Audia S. Angine bulleuse hémorragique : une maladie rare, un diagnostic facile – à propos de 2 cas. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.238] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
30
|
Nicolas B, Berthier S, Samson M, Guilhem A, Leguy-Seguin V, Lakomy D, Falvo N, Bonnotte B, Audia S. Prévalence et signification de la thrombopénie associée aux anticorps antiphospholipides : étude rétrospective monocentrique. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
31
|
Picot D, Nicolas B, Houedakor J, Guillou F, Desrues L, Colin A. Libre pesée : contribution à l’accès aux soins nutritionnels des personnes handicapées en fauteuil roulant. NUTR CLIN METAB 2016. [DOI: 10.1016/j.nupar.2016.04.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
32
|
Nicolas B, Amoureux L, Péchinot A, Chapuis A, Bador J, Aho S, Piroth L, Neuwirth C, de Curraize C. BMR-02 - Étude de la sensibilité à la témocilline chez les entérobactéries productrices de β-lactamases à spectre élargi isolées des urines et facteurs de risque de résistance liés au patient. Med Mal Infect 2016. [DOI: 10.1016/s0399-077x(16)30311-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
33
|
Babel M, Pasteau F, Fraudet B, Achille S, Colin A, Nicolas B, Durufle A, Le Pape L, Gallien P. Assessment of a navigation assistance system for power wheelchair. Ann Phys Rehabil Med 2015. [DOI: 10.1016/j.rehab.2015.07.241] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
34
|
Gallien P, Nicolas B, Durufle A, Robineau S, Petrilli S, Autret K, Houedakor J, Le Meur C. Physical training and muscle strengthening in multiple sclerosis. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.1104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
35
|
Nicolas B, Robineau-Beneux S, Lebot M, Durufle A, Petrilli S, Gallien P. Prevalence of pressure sores in EPHAD in Britanny. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.545] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
36
|
Duruflé A, Gallien P, Nicolas B, Colin A. Analysis of the medical causes of death in cerebral palsy. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.1236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
37
|
Nicolas B, Colin A, Durufle A, Achille S, Dauvergne F, Lepape L, Gallien P. BreizhPC network: First health network dedicated to adults with cerebral palsy. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.1506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
38
|
Robineau-Beneux S, Durufle A, Nicolas B, Chopin A, Lebot M, Petrilli S, Gallien P. Management of pressure sore at home, back from a survey about 2013 liberal nurses in Lille et Vilaine. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.1497] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
39
|
Leroux R, Gruson M, Durufle A, Nicolas B, Coignard P, Lassalle A, Colin A, Gallien P, Groupe P, Chapelain F. Cognitive disorders in adults with cerebral palsy. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.1238] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
40
|
Duruflé A, Gallien P, Nicolas B, Colin A. Étude des causes médicales de décès dans la paralysie cérébrale. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.1296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
41
|
Pons C, Brochard S, Gallien P, Nicolas B, Duruflé A, Roquet M, Rémy-Néris O, Garlantezec R. Medical and rehabilitative care profiles in adults with cerebral palsy in Britanny. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.1517] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
42
|
Gallien P, Rouxel A, Brunet I, Larget A, Deburghgraeve V, Nicolas B, Groupe N. Fatigue and multiple sclerosis: Experience of a therapeutic education seminar. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.1110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
43
|
Duruflé-Tapin A, Colin A, Nicolas B, Lebreton C, Dauvergne F, Gallien P. Analysis of the medical causes of death in cerebral palsy. Ann Phys Rehabil Med 2014; 57:24-37. [DOI: 10.1016/j.rehab.2013.11.002] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2013] [Revised: 11/12/2013] [Accepted: 11/14/2013] [Indexed: 11/25/2022]
|
44
|
Breuvart E, Berthier S, Hars B, Nicolas B, Leguy-Seguin V, Samson M, Milliere A, Bonnotte B, Lorcerie B. Étude de la conformité des prescriptions d’inhibiteurs de la pompe à protons aux recommandations HAS de 2009 : étude prospective sur 208 patients. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.10.051] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
45
|
Gaillard F, Lucas C, Robineau S, Durufle-Tapin A, Petrilli S, Nicolas B, Autret K, Le Meur C, Gallien P. Syndrome de la pince mésentérique et dénutrition. Ann Phys Rehabil Med 2013. [DOI: 10.1016/j.rehab.2013.07.119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
46
|
Petrilli S, Nicolas B, Durufle A, Gallien P, Robineau S, Le Meur C, Autret K, Cristina MC, Debet J, Houedakor J. Use of Entonox in PMR adult center, annual assessment practices. Ann Phys Rehabil Med 2013. [DOI: 10.1016/j.rehab.2013.07.246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
47
|
Chapelain F, Gruson M, Le Roux R, Autret K, Nicolas B, Gallien P. Impacts cliniques d’une rééducation cognitive en groupe sur le fonctionnement au quotidien de patients SEP. Ann Phys Rehabil Med 2013. [DOI: 10.1016/j.rehab.2013.07.902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
48
|
Chapelain F, Dardier V, Bernicot J, Autret K, Nicolas B, Gallien P. Étude exploratoire des capacités pragmatiques du langage dans la sclérose en plaques. Ann Phys Rehabil Med 2013. [DOI: 10.1016/j.rehab.2013.07.911] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
49
|
Achille-Fauveau S, Gallien P, Durufle-Tapin A, Nicolas B, Grangeret V, Colin A. Parentalité et handicap : parcours d’une maman avec paralysie cérébrale. Ann Phys Rehabil Med 2013. [DOI: 10.1016/j.rehab.2013.07.118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
50
|
Autret K, Durufle-Tapin A, Robineau S, Nicolas B, Gallien P, Petrilli S, Le Meur C. Bilan à cinq ans d’une unité post-réanimation (UPR) au Pôle Saint-Hélier, Rennes. Ann Phys Rehabil Med 2013. [DOI: 10.1016/j.rehab.2013.07.711] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|